Cash & equivalents increased 32.8%
Cash & equivalents changed +32.8% from the comparable as-filed period.
$662.3M→$879.9M2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →ESTC financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Free-cash-flow proxy increased 26.1%
Free-cash-flow proxy changed +26.1% from the comparable as-filed period.
$104.2M→$131.4M1 prior comparisons
Operating income decreased 149.7%
Operating income changed -149.7% from the comparable as-filed period.
-$9.4M→-$23.6M1 prior comparisons
Operating cash flow increased 25.9%
Operating cash flow changed +25.9% from the comparable as-filed period.
$104.8M→$132.0M1 prior comparisons
Operating margin moved 266 bp lower
Operating margin changed -266 basis points from the comparable as-filed period.
-2.27%→-4.93%1 prior comparisons
Net debt decreased 234.3%
Net debt changed -234.3% from the comparable as-filed period.
-$92.3M→-$308.7M2 prior comparisons
Net income increased 32.0%
Net income changed +32.0% from the comparable as-filed period.
-$24.6M→-$16.7M1 prior comparisons
Stockholders' equity increased 33.5%
Stockholders' equity changed +33.5% from the comparable as-filed period.
$971.4M→$1.3B1 prior comparisons
Gross margin moved 221 bp lower
Gross margin changed -221 basis points from the comparable as-filed period.
76.70%→74.50%1 prior comparisons
Revenue increased 15.1%
Revenue changed +15.1% from the comparable as-filed period.
$415.3M→$478.1M1 prior comparisons
Total assets increased 18.9%
Total assets changed +18.9% from the comparable as-filed period.
$2.5B→$3.0B2 prior comparisons
Debt / assets moved 356 bp lower
Debt / assets changed -356 basis points from the comparable as-filed period.
22.58%→19.03%2 prior comparisons
Cash / debt moved 3784 bp higher
Cash / debt changed +3784 basis points from the comparable as-filed period.
116.20%→154.04%2 prior comparisons
Current liabilities increased 15.1%
Current liabilities changed +15.1% from the comparable as-filed period.
$900.8M→$1.0B2 prior comparisons
Debt / equity moved 1464 bp lower
Debt / equity changed -1464 basis points from the comparable as-filed period.
58.68%→44.05%1 prior comparisons
Debt / revenue moved 1779 bp lower
Debt / revenue changed -1779 basis points from the comparable as-filed period.
137.26%→119.47%1 prior comparisons
Working capital / assets moved 1073 bp lower
Working capital / assets changed -1073 basis points from the comparable as-filed period.
38.73%→28.00%2 prior comparisons
Receivables / revenue moved 400 bp lower
Receivables / revenue changed -400 basis points from the comparable as-filed period.
53.45%→49.45%1 prior comparisons
Working capital decreased 14.0%
Working capital changed -14.0% from the comparable as-filed period.
$977.5M→$840.4M2 prior comparisons
R&D / revenue moved 275 bp lower
R&D / revenue changed -275 basis points from the comparable as-filed period.
26.28%→23.53%1 prior comparisons
Free-cash-flow margin moved 240 bp higher
Free-cash-flow margin changed +240 basis points from the comparable as-filed period.
25.09%→27.49%1 prior comparisons
Operating cash-flow margin moved 237 bp higher
Operating cash-flow margin changed +237 basis points from the comparable as-filed period.
25.24%→27.61%1 prior comparisons
SBC / revenue moved 120 bp lower
SBC / revenue changed -120 basis points from the comparable as-filed period.
16.84%→15.64%1 prior comparisons
Gross profit increased 11.8%
Gross profit changed +11.8% from the comparable as-filed period.
$318.5M→$356.2M1 prior comparisons
Shares outstanding decreased 1.2%
Shares outstanding changed -1.2% from the comparable as-filed period. The change ranks at the 14th percentile of 7 prior comparable changes.
106,270,940→104,991,2807 prior comparisons
Trade receivables increased 6.5%
Trade receivables changed +6.5% from the comparable as-filed period.
$222.0M→$236.4M2 prior comparisons
Current ratio decreased 13.2%
Current ratio changed -13.2% from the comparable as-filed period.
2.09→1.812 prior comparisons
Capex / revenue moved 3 bp lower
Capex / revenue changed -3 basis points from the comparable as-filed period.
0.16%→0.12%1 prior comparisons
Stock-based compensation increased 6.9%
Stock-based compensation changed +6.9% from the comparable as-filed period.
$69.9M→$74.8M1 prior comparisons
Research & development increased 3.1%
Research & development changed +3.1% from the comparable as-filed period.
$109.1M→$112.5M1 prior comparisons
Capital expenditure decreased 10.1%
Capital expenditure changed -10.1% from the comparable as-filed period.
$656,000→$590,0001 prior comparisons
Current assets decreased 0.0%
Current assets changed -0.0% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$1.9B→$1.9B2 prior comparisons
Gross debt increased 0.2%
Gross debt changed +0.2% from the comparable as-filed period.
$570.0M→$571.2M2 prior comparisons
Reported total debt increased 0.2%
Reported total debt changed +0.2% from the comparable as-filed period.
$570.0M→$571.2M2 prior comparisons
Net income increased 145.5%
Net income changed +145.5% from the comparable as-filed period.
-$17.1M→$7.8M1 prior comparisons
Gross profit increased 20.5%
Gross profit changed +20.5% from the comparable as-filed period.
$284.9M→$343.4M1 prior comparisons
Operating margin moved 135 bp higher
Operating margin changed +135 basis points from the comparable as-filed period.
-1.21%→0.14%1 prior comparisons
Cash & equivalents increased 26.2%
Cash & equivalents changed +26.2% from the comparable as-filed period.
$584.0M→$737.2M0 prior comparisons
Debt increased 0.2%
Debt changed +0.2% from the comparable as-filed period.
$569.4M→$570.6M1 prior comparisons
Gross margin moved 177 bp higher
Gross margin changed +177 basis points from the comparable as-filed period.
74.57%→76.34%1 prior comparisons
Stock-based compensation increased 20.9%
Stock-based compensation changed +20.9% from the comparable as-filed period.
$64.6M→$78.1M1 prior comparisons
Revenue increased 17.7%
Revenue changed +17.7% from the comparable as-filed period.
$382.1M→$449.9M1 prior comparisons
Research & development increased 22.2%
Research & development changed +22.2% from the comparable as-filed period.
$93.6M→$114.4M1 prior comparisons
Operating income increased 113.2%
Operating income changed +113.2% from the comparable as-filed period.
-$4.6M→$611,0001 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.